Related Experiment Video
Updated: Jun 11, 2026

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
Longitudinal Insights Into Childhood Onset Facioscapulohumeral Dystrophy: A 5-Year Natural History Study
Jildou N Dijkstra1, Helena T M Boon1, Anne Koekkoek1
1From the Department of Neurology (J.N.D., H.T.M.B., N.V.A., B.G.M.V.E., N.C.V.); Department of Pediatric Neurology (J.N.D., H.T.M.B., A.K., C.E.E.), Donders Institute for Brain, Cognition and Behaviour, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, The Netherlands; Department of Neurology (R.J.M.G.), Jönköping, and Department of Biomedical and Clinical Sciences, Linköping University, Sweden; Department of Rehabilitation (M.M.P., S.L.S.H.), Donders Institute for Brain, Cognition and Behaviour, Amalia Children's Hospital; and Department of Neurology (N.V.A.), Clinical Neuromuscular Imaging Group, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
Insights
Childhood facioscapulohumeral dystrophy (FSHD) shows variable progression, often unnoticed by patients. Sensitive outcome measures like FSHD-CS and muscle ultrasonography are key for tracking disease in pediatric trials.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Background:
- Facioscapulohumeral dystrophy (FSHD) is an inherited muscle disorder with a significant proportion of childhood-onset cases.
- Understanding the natural history and identifying reliable outcome measures for pediatric FSHD is critical for effective clinical management and therapeutic development.
Purpose of the Study:
- To investigate the natural history of childhood-onset facioscapulohumeral dystrophy (FSHD) over a 5-year period.
- To identify sensitive clinical and functional outcome measures for pediatric FSHD.
Main Methods:
- A prospective, nationwide cohort study (iFocus) involving 20 patients with childhood-onset FSHD.
- Regular assessments included manual muscle testing, functional muscle tests, FSHD clinical score (FSHD-CS), FSHD clinical severity scale (FSHD-CSS), and muscle ultrasonography (MUS) over 5 years.
Main Results:
- Eighteen patients completed the 5-year follow-up, revealing variable disease progression with a mean FSHD-CS increase of 1.6.
- Despite objective progression, 89% of participants did not perceive any change in their condition.
- The most sensitive outcome measures identified were FSHD-CS (SRM 1.07), FSHD-CSS (SRM 0.92), and MUS (SRM 0.68).
Conclusions:
- Disease progression in childhood FSHD is variable and often clinically unperceived, emphasizing the need for sensitive outcome measures.
- Quality of life improved, and fatigue decreased over the study period.
- Future pediatric FSHD studies should utilize larger cohorts, incorporate reachable workspace assessments, muscle ultrasonography, and the FSHD functional composite outcome measure (FSHD-COM).
Background And Objectives:
Facioscapulohumeral dystrophy (FSHD) is an inherited muscle disorder, with childhood onset in 20% of patients. Understanding the natural history of childhood FSHD and identifying clinical and functional outcome measures are crucial for clinical care and future trials.
Methods:
In a prospective nationwide FSHD cohort study (iFocus), 20 childhood-onset patients were assessed at baseline, 2 years, and 5 years. Assessments included manual muscle and functional muscle tests, FSHD clinical score (FSHD-CS), FSHD clinical severity scale (FSHD-CSS), and muscle ultrasonography (MUS).
Results:
Eighteen patients (aged 2-17 years at baseline) completed the 5-year follow-up. Disease progression varied, with a mean FSHD-CS increase of 1.6. Despite objective disease progression, most participants (89%) did not perceive change. The most sensitive outcome measures were FSHD-CS (standardized response mean [SRM] 1.07), FSHD-CSS score (SRM 0.92), and MUS findings (SRM 0.68). Baseline characteristics did not predict progression.
Discussion:
Disease progression was variable and often remained unnoticed by participants. Quality of life improved, and fatigue levels decreased over 5 years. The relatively slow progression and physiologic growth highlight the need for sensitive end points within a 1-2-year time frame. Future pediatric studies should consider larger international cohorts, assess reachable workspace, and include MUS and FSHD functional composite outcome measure (FSHD-COM).
More Related Videos
Related Concept Videos
Longitudinal Research
Satellite Stem Cells and Muscular Dystrophy
Changes in the Appendicular Skeleton with Age
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Longitudinal Studies
Huntington Disease l: Introduction

